Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)

Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)

US Patent 9242933 · Granted Jan 26, 2016

Estimated economic value: $303,602,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthesis of novel ketone body analogs for use as a nutritional supplement2023
Organic reactions carried out in aqueous solution in the presence of a hydroxyal2022
Organic reactions carried out in aqueous solution in the presence of a hydroxyal2020
Fused heterocyclic compounds as S1P modulators2020
Fused heterocyclic compounds as S1P modulators2020
Fused heterocyclic compounds as S1P modulators2020
Inhibitor compounds of phosphodiesterase type 10A2019
Fused (hetero)cyclic compounds as S1P modulators2019
Fused (hetero)cyclic compounds as S1P modulators2019
Quinoline compounds suitable for treating disorders that respond to the modulati2018
Tricyclic quinoline and quinoxaline derivatives2018
Tricyclic quinoline and quinoxaline derivatives2018